Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Net Income (2020 - 2025)

Biofrontera (BFRI) has 6 years of Net Income data on record, last reported at -$6.6 million in Q3 2025.

  • For Q3 2025, Net Income fell 17.29% year-over-year to -$6.6 million; the TTM value through Sep 2025 reached -$17.6 million, down 36.88%, while the annual FY2024 figure was -$17.8 million, 11.78% up from the prior year.
  • Net Income reached -$6.6 million in Q3 2025 per BFRI's latest filing, down from -$5.3 million in the prior quarter.
  • Across five years, Net Income topped out at $5.6 million in Q1 2022 and bottomed at -$16.0 million in Q3 2021.
  • Average Net Income over 5 years is -$4.9 million, with a median of -$4.2 million recorded in 2025.
  • Peak YoY movement for Net Income: plummeted 7615.43% in 2021, then surged 257.36% in 2022.
  • A 5-year view of Net Income shows it stood at -$14.5 million in 2021, then soared by 80.8% to -$2.8 million in 2022, then skyrocketed by 226.61% to $3.5 million in 2023, then crashed by 139.59% to -$1.4 million in 2024, then tumbled by 376.29% to -$6.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income were -$6.6 million in Q3 2025, -$5.3 million in Q2 2025, and -$4.2 million in Q1 2025.